CELG.RT
Bristol-Myers Squibb Rights
CELG.RT
CELG.RT
21 hedge funds and large institutions have $5.2M invested in Bristol-Myers Squibb Rights in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.39K | |
| 2 | +$757 | |
| 3 | +$600 | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$175 |
Top Sellers
| 1 | -$3.65K | |
| 2 | -$422 | |
| 3 | -$16 | |
| 4 |
Morgan Stanley
New York
|
-$2 |